Acute coronary and peripheral arteral thrombosis following percutaneous coronary intervention in a patient with previously undiagnosed inherited thrombophilia

Canadian Journal of Cardiology

Volumn 19, Issue 9, 2003, Pages 1063-1065

  Nanas, John N ^a   Gougoulakis, Alekos ^a   Kanakakis, John ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Angioplasty; Genes; Thrombosis

Indexed keywords

PROTHROMBIN; RETEPLASE; TICLOPIDINE; WARFARIN;

ADULT; ANGINA PECTORIS; ANGIOPLASTY; AORTA BALLOON; ARTERY THROMBOSIS; ARTICLE; BALLOON DILATATION; CARDIOGENIC SHOCK; CASE REPORT; CLAUDICATION; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY THROMBOSIS; CORONARY STENT; GENE MUTATION; HOSPITAL DISCHARGE; HUMAN; INHERITANCE; LABORATORY TEST; MALE; RECURRENT DISEASE; ST SEGMENT ELEVATION; SURVIVAL; THROMBOPHILIA; TRANSLUMINAL CORONARY ANGIOPLASTY; TREADMILL EXERCISE; ACUTE DISEASE; FEMORAL ARTERY; GENETIC PREDISPOSITION; GENETICS; HEART INFARCTION; ISCHEMIA; LEG; NUCLEOTIDE SEQUENCE; RETREATMENT; STENT; THROMBECTOMY; THROMBOSIS; VASCULARIZATION;

ACUTE DISEASE; ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY THROMBOSIS; DNA MUTATIONAL ANALYSIS; FEMORAL ARTERY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISCHEMIA; LEG; MALE; MYOCARDIAL INFARCTION; PROTHROMBIN; RETREATMENT; STENTS; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS;

EID: 0042384576     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fischman DL, Leon MB, Baim DS, et al. for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
2. Margaglione M, Brancaccio V, Giuliani N, et al. Increased risk for venous thrombosis in carriers of the prothrombin G ® A20210 gene variant. Ann Intern Med 1998;129:89-93.
3. De Stefano V, Chiusolo P, Paciaroni K, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998;91:3562-5.
4. Folsom AR, Rosamond WD, Shahar E, et al. for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999;100:736-42.
5. Markus HS, Hambley H. Neurology and the blood: Haematological abnormalities in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998;64:150-9.
6. Martinez HR, Rangel Guerra RA, Marfil LJ. Ischemic stroke due to deficiency of coagulation inhibitors: Report of 10 young adults. Stroke 1993;24:19-25.
7. Barinagarrementeria F, Cantu-Brito C, De La Peria A, Izaguirre R. Prothrombotic states in young people with idiopathic stroke: A prospective study. Stroke 1994;25:287-90.
8. Munts AG, Van Genderen PJ, Dippel DW, Van Kooten F, Koudstaal PJ. Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 1998;245:21-5.
9. Albucher JF, Guiraud-Chaumeil B, Chollet F, Vadroy Y, Sie P. Frequency of resistance to activated protein C due to factor V mutation in young patients with ischaemic stroke. Stroke 1996;27:766-77.
10. Markus HS, Zhang Y, Jeffery S. Screening for the factor-V Arg 506 Gln mutation in patients with TIA and stroke. Cerebrovasc Dis 1996;6:360-2.
11. Hankey GJ, Eikelboom JW, Van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001;32:1793-803.
12. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich J. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
13. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999;99:999-1004.
14. Bertina RM, Rosendaal FR. Venous thrombosis - The interaction of genes and environment. N Engl J Med 1998;338:1840-1.
15. Doggen CJM, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors. Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998;97:1037-41.
16. Arruda VR, Siquiera LH, Chiaparini LC, et al. Prevalence of the prothrombin gene variant 20210 G-A among patients with myocardial infarction. Cardiovasc Res 1998;37:42-5.
17. Burzotta F, Paciaroni K, De Stefano V, et al. Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease. Eur Heart J 2002;23:26-30.
18. Eikelboom JW, Baker RI, Parsons R, Taylor RR, Van Bockxmeer FM. No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost 1998;80:878-80.
19. Gardemann A, Arsic T, Katz N, et al. The factor II G20210A and factor V G1691A gene transitions and coronary heart disease. Thromb Haemost 1999;81:208-13.
20. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
21. Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.